Can a smartphone app ease Self-Stigma for moms battling addiction?

NCT ID NCT07211867

Recruiting now Symptom relief Sponsor: Washington University School of Medicine Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a digital app called Enhearten designed to reduce self-stigma in pregnant and postpartum women with substance use disorder. The app provides just-in-time support to help women feel less judged and stay on track with addiction treatment. Researchers will compare the app group to a waitlist control group, measuring stigma levels and treatment outcomes in 152 participants.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Enhearten digital app with ecological momentary intervention
What this could lead to: If successful, this app could provide a scalable way to reduce self-stigma and support recovery in pregnant and postpartum women with substance use disorder.
What could go wrong: This is an early-stage trial with 152 participants, so results may not apply broadly. The app relies on self-reported outcomes, which can be biased, and the intervention may not work for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SUBSTANCE USE DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

substance-related disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SUBSTANCE USE DISORDER

Contacts and locations

Locations

Washington University School of Medicine
RECRUITING

St Louis, Missouri, 63110, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.